Study S002122

The Evaluation of the Efficacy and Safety of Switching to Once-daily IDegLira in Patients With Type 2 Diabetes Receiving Premixed Insulin Therapy, a Multi-center, Randomized Control Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06408532
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: SINGLE
Status: UNKNOWN
Enrollment: 256
Start: 2024-04-30
Primary completion: 2024-10-30
Lead sponsor: Peking University People's Hospital
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:IDegLira; DRUG:Premixed insulin
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Hemoglobin A1c (HbA1c) [From baseline to the end of the study (week 0-week 14 ± 7days).]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.